Clinical Trial Update: A Non-Interventional Clinical Study to Evaluate Long-Term Safety and Effectiveness of HUMIRA (Adalimumab) in Pediatric Patients With Moderately to Severely Active Crohn's Disease (CD)

View source ↗

Summary

An ongoing non-interventional study evaluating long-term safety and effectiveness of Humira (adalimumab) in pediatric patients with moderately to severely activ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Humira (adalimumab)

Snippet

Sponsor: AbbVie | Conditions: Crohn's Disease | Status: ACTIVE_NOT_RECRUITING